MA
Monica Alvisi
Associate Director, Alliances And Program Management at Forbius
View Monica's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Jan 2017 - Present · 8 years
Associate Director, Alliances And Program Management
Aug 2017 - Present · 7 years and 5 months
Program Manager
Jan 2017 - Jul 2017 · 6 months
Program Manager
Oct 2012 - Sep 2016 · 3 years and 11 months
Company Details
11-50 Employees
About Forbius: Targeting EGFR and TGF-β Pathways in Cancer and Fibrosis Forbius is a clinical stage company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. We use our strength in biological understanding and diverse protein engineering technologies to design superior inhibitors of validated pathways. We have particularly deep expertise in targeting the transforming growth factor-beta (TGF-β) and epidermal growth factor receptor (EGFR) pathways. For both of these pathways, there is a significant body of evidence validating their role as drivers of multiple life-threatening conditions, including cancer and fibrosis. However, in the case of the EGFR pathway, the majority of patients do not benefit from currently marketed EGFR inhibitors; in the case of the TGF-β pathway, no agent targeting this pathway has yet been approved. By using multiple complementary platform technologies, Forbius’ team overcame barriers that prevented the development of effective therapeutics targeting these pathways. For more information, please visit www.forbius.com.
Year Founded
2011
Social Media
LinkedinTwitter
Industry
Pharmaceutical Manufacturing
HQ Location
701 Brazos St. Suite 930 Austin, Texas 78701, US
Keywords
PharmaceuticalsBiotechnologycancerrare diseasesfibrosis
Discover More About Cleveland Clinic

Find verified contacts of Monica Alvisi in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.